236 related articles for article (PubMed ID: 15782137)
1. RKIP downregulates B-Raf kinase activity in melanoma cancer cells.
Park S; Yeung ML; Beach S; Shields JM; Yeung KC
Oncogene; 2005 May; 24(21):3535-40. PubMed ID: 15782137
[TBL] [Abstract][Full Text] [Related]
2. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.
Schuierer MM; Bataille F; Hagan S; Kolch W; Bosserhoff AK
Cancer Res; 2004 Aug; 64(15):5186-92. PubMed ID: 15289323
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
4. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma.
Schuierer MM; Bataille F; Weiss TS; Hellerbrand C; Bosserhoff AK
Oncol Rep; 2006 Sep; 16(3):451-6. PubMed ID: 16865242
[TBL] [Abstract][Full Text] [Related]
5. The role of Raf kinase inhibitor protein (RKIP) in health and disease.
Keller ET; Fu Z; Brennan M
Biochem Pharmacol; 2004 Sep; 68(6):1049-53. PubMed ID: 15313400
[TBL] [Abstract][Full Text] [Related]
6. Raf kinase inhibitory protein inhibits beta-cell proliferation.
Zhang L; Fu Z; Binkley C; Giordano T; Burant CF; Logsdon CD; Simeone DM
Surgery; 2004 Sep; 136(3):708-15. PubMed ID: 15349122
[TBL] [Abstract][Full Text] [Related]
7. Raf kinase inhibitor protein regulation of raf and MAPK signaling.
Hagan S; Garcia R; Dhillon A; Kolch W
Methods Enzymol; 2006; 407():248-59. PubMed ID: 16757329
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
Wellbrock C; Marais R
J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
[TBL] [Abstract][Full Text] [Related]
9. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.
Hagan S; Al-Mulla F; Mallon E; Oien K; Ferrier R; Gusterson B; García JJ; Kolch W
Clin Cancer Res; 2005 Oct; 11(20):7392-7. PubMed ID: 16243812
[TBL] [Abstract][Full Text] [Related]
10. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein.
Keller ET; Fu Z; Brennan M
J Cell Biochem; 2005 Feb; 94(2):273-8. PubMed ID: 15565643
[TBL] [Abstract][Full Text] [Related]
11. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis.
Chen Y; Ouyang GL; Yi H; Li MY; Zhang PF; Li C; Li JL; Liu YF; Chen ZC; Xiao ZQ
J Proteome Res; 2008 Dec; 7(12):5254-62. PubMed ID: 19367706
[TBL] [Abstract][Full Text] [Related]
12. Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas.
Cardile V; Malaponte G; Loreto C; Libra M; Caggia S; Trovato FM; Musumeci G
Acta Histochem; 2013 Oct; 115(8):795-802. PubMed ID: 23601922
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UI-152.
Kim YK; Ahn SK; Lee M
Cancer Lett; 2012 Jul; 320(2):215-24. PubMed ID: 22425959
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
15. Induction of Raf kinase inhibitor protein contributes to macrophage differentiation.
Schuierer MM; Heilmeier U; Boettcher A; Ugocsai P; Bosserhoff AK; Schmitz G; Langmann T
Biochem Biophys Res Commun; 2006 Apr; 342(4):1083-7. PubMed ID: 16513087
[TBL] [Abstract][Full Text] [Related]
16. Growth factors rescue cutaneous melanoma cells from apoptosis induced by knockdown of mutated (V 600 E) B-RAF.
Christensen C; Guldberg P
Oncogene; 2005 Sep; 24(41):6292-302. PubMed ID: 16007203
[TBL] [Abstract][Full Text] [Related]
17. RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells.
Fan F; Feng L; He J; Wang X; Jiang X; Zhang Y; Wang Z; Chen Y
Carcinogenesis; 2008 Jun; 29(6):1157-63. PubMed ID: 18515281
[TBL] [Abstract][Full Text] [Related]
18. Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway.
Shin SY; Rath O; Choo SM; Fee F; McFerran B; Kolch W; Cho KH
J Cell Sci; 2009 Feb; 122(Pt 3):425-35. PubMed ID: 19158341
[TBL] [Abstract][Full Text] [Related]
19. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
[TBL] [Abstract][Full Text] [Related]
20. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.
Bloethner S; Chen B; Hemminki K; Müller-Berghaus J; Ugurel S; Schadendorf D; Kumar R
Carcinogenesis; 2005 Jul; 26(7):1224-32. PubMed ID: 15760917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]